Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Orchid Island Capital Announces April 2014 Monthly Dividend and March 31, 2014 RMBS Portfolio Characteristics
-
Apple (AAPL): Evidence of Appetite in China for the iPhone 6, Says Cantor
-
Energy XXI Announces Early Termination of Hart-Scott-Rodino Waiting Period in Connection With Pending Acquisition of EPL Oil & Gas
-
AGTC Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Energy XXI to Present at IPAA Oil & Gas Investment Symposium
-
Notable Analyst Rating Changes 04/01: (NVDA) (UAL) (RBCN) Upgraded; (INVN) (POT) (OAS) Downgraded
-
Cantor Fitzgerald Downgrades Potash Corp. (POT) to Hold
-
Cantor Fitzgerald Starts Cancer Genetics, Inc. (CGIX) at Buy
-
Rosetta Genomics (ROSG) Enters $10M Ordinary Share Controlled Equity Offering
-
Cantor Fitzgerald Starts Valeant Pharmaceuticals (VRX) at Buy
-
Cantor Fitzgerald Starts Oracle (ORCL) at Buy; Engineered Systems Seen as Game Changer
-
Cubist (CBST) PT Raised to $73 on Likely Approval of Tedizolid - Cantor
-
Applied Genetic Technologies (AGTC) IPO Opens Higher
-
Humana (HUM) Price Target Raised to $130 at Cantor Fitzgerald
-
Google (GOOG) Product Listing Ads 'Taking Off' - Analyst
-
Applied Genetic Technologies (AGTC) IPO Prices at $12, Below Range
-
AGTC Announces Pricing of Initial Public Offering
-
Cantor Sees Limited Impact on Hologic's (HOLX) ThinPrep Vols Following FDA Panel; Updates on Management Meeting
-
Notable Analyst Rating Changes 03/21: (EMR) (BBRY) (UTX) Upgraded; (SYMC) (WAG) (AMRI) Downgraded
-
Energy XXI to Present at Howard Weil Energy Conference
-
Cantor Cuts Walgreen (WAG) to Sell, Stock Seen as Overpriced
-
Energy XXI Participates in Central Gulf of Mexico Lease Sale 231
-
Social Media Engagement Strong in February, Says Cantor (FB) (TWTR) (YELP) (LNKD)
-
Cantor Fitzgerald Starts Hyperion Therapeutics (HPTX) at Buy
-
Galena Biopharma (GALE) Remains 'Sell' at Cantor Fitzgerald, PT Cut to $3
-
Cantor Fitzgerald Downgrades Oncothyreon (ONTY) to Hold
-
eBay (EBAY)/PayPal Spin-Off Will be Determined by Core Performance - Cantor
-
Energy XXI to Acquire EPL Oil & Gas
-
Orchid Island Capital Announces March 2014 Monthly Dividend and February 28, 2014 MBS Portfolio Characteristics
-
Cantor Fitzgerald Starts Eagle Pharmaceuticals (EGRX) at Buy
-
Cantor Fitzgerald Upgrades SAFEWAY (SWY) to Hold
-
Notable Analyst Rating Changes 03/07: (GTAT) (CCRN) (PRU) Upgraded; (ALU) (NMRX) (VMEM) Downgraded
-
Cross Country Healthcare (CCRN) Rebounds on Two Upgrades
-
Cantor Fitzgerald Upgrades Cross Country Healthcare (CCRN) to Buy
-
Bimini Capital Management Announces Fourth Quarter 2013 Results
-
Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2013 Financial Results and Recent Highlights
-
Analyst Comments on Latest Big Data Alliance (DATA) (SPLK)
-
Apple (AAPL) Q2 Sales May Fall by More than Seasonal Average - Cantor
-
Apple's (AAPL) Maestri Has Reputation for Being Shareholder Friendly - Cantor
-
OvaScience (OVAS) Prices 5M Offering at $10/Share
-
UPDATE: Cantor Lowers Intuitive Surgical (ISRG) to Hold; Recovery Largely Being Baked In
-
Smatwatches and Ingestible Computing Discussed at Mobile World Congress (AAPL)
-
Sunesis Pharma (SNSS) Prices $43M Common Stock + Warrants Offering
-
Sunesis Announces Pricing of a $43.0 Million Public Offering of Common Stock and Warrants
-
Energy XXI to Present at Raymond James' Institutional Investor Conference
-
Sunesis Pharmaceuticals (SNSS) Plans Common, Warrants Offering
-
Sunesis Announces Proposed Public Offering of Common Stock and Warrants
-
Sucampo Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2013 Financial and Operating Results
-
Cantor Fitzgerald Downgrades Jazz Pharmaceuticals (JAZZ) to Hold on Xyrem Risk
-
Juniper Networks (JNPR) / Nokia (NOK) Combo Makes Sense, Says Cantor

